ANVS short interest
Annovis Bio Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 5,895,922 |
|---|---|
| Change vs prior report | -126,118 (-2.1%) |
| Change over six months | +82.3% |
| Days to cover | 5.95 (sector: 3.78) |
| Average daily volume | 990,573 |
| Rank in Healthcare | #327 of 922 by days to cover |
ANVS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 5,895,922 | -2.1% | 5.95 | 990,573 |
| 2026-09-15 | 6,022,040 | +20.7% | 3.19 | 1,889,918 |
| 2026-08-31 | 4,989,785 | +0.5% | 9.59 | 520,405 |
| 2026-08-14 | 4,964,649 | -4.4% | 8.16 | 608,131 |
| 2026-07-31 | 5,193,076 | -4.7% | 9.45 | 549,684 |
| 2026-07-15 | 5,450,385 | +12.1% | 5.05 | 1,079,470 |
| 2026-06-30 | 4,864,454 | +1.2% | 5.36 | 908,320 |
| 2026-06-15 | 4,804,638 | -4.3% | 4.04 | 1,188,765 |
| 2026-05-29 | 5,021,073 | +7.4% | 3.13 | 1,602,998 |
| 2026-05-15 | 4,674,614 | -3.0% | 4.85 | 964,619 |
| 2026-04-30 | 4,816,770 | +1.2% | 4.96 | 970,735 |
| 2026-04-15 | 4,760,673 | +47.2% | 2.61 | 1,824,657 |
| 2026-03-31 | 3,234,406 | +16.4% | 6.20 | 521,946 |
| 2026-03-13 | 2,778,124 | +1.2% | 9.57 | 290,216 |
| 2026-02-27 | 2,745,085 | -3.1% | 7.29 | 376,460 |
| 2026-02-13 | 2,833,149 | -3.5% | 8.33 | 339,980 |
| 2026-01-30 | 2,935,736 | -6.3% | 5.49 | 535,090 |
| 2026-01-15 | 3,133,837 | +3.0% | 5.48 | 571,749 |
| 2025-12-31 | 3,044,065 | +6.5% | 6.62 | 459,650 |
| 2025-12-15 | 2,858,006 | +1.0% | 2.71 | 1,054,422 |
| 2025-11-28 | 2,829,273 | +115.2% | 1.00 | 7,715,624 |
| 2025-11-14 | 1,314,516 | +27.3% | 3.02 | 434,680 |
| 2025-10-31 | 1,032,901 | -20.4% | 1.49 | 695,452 |
| 2025-10-15 | 1,298,376 | -7.1% | 1.00 | 1,903,993 |
| 2025-09-30 | 1,398,175 | -11.9% | 6.72 | 207,938 |
import finzdata as yf
yf.Ticker("ANVS").short_interest # every report since 2017
yf.Client().short_interest(["ANVS"], start="2018-01-01")Healthcare short interest · ANVS price history · Who owns ANVS · All short interest